Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
7,943,500
-
Share change
-
-803,742
-
Total reported value
-
$13,898,000
-
Put/Call ratio
-
0%
-
Price per share
-
$1.75
-
Number of holders
-
30
-
Value change
-
-$1,387,590
-
Number of buys
-
10
-
Number of sells
-
15
Institutional Holders of KEMPHARM INC - COM (KMPH) as of Q2 2019
As of 30 Jun 2019 KEMPHARM INC - COM (KMPH) had 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 7,943,500 shares of stock of the company.
Largest 10 holders included DSC Advisors, L.P., VANGUARD GROUP INC, Arete Wealth Advisors, LLC, Creative Planning, Alyeska Investment Group, L.P., COWEN INC., GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, ROYAL BANK OF CANADA, and BlackRock Inc..
This table shows 30 institutional shareholders of the security as of 30 Jun 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.